TPM3-NTRK1 is the most commonly identified fusion gene, as TrkA itself was originally separated from TPM3-TrkA fusion gene of colon carcinoma, with a detection rate of 0.5–1%. This evidence concerns the gene TPM3 and colon carcinoma.